Search research articles
Contact Us
Filters
Showing results (281-290 of 426) with videos related to
Page
of 43
Sort By:
Giornale Italiano Di Cardiologia (2006)
|
April 27, 2023
[Uncertainties in cardiovascular risk factors: sodium-glucose cotransporter 2 inhibitors for all diabetic patients with high cardiovascular risk and in all patients with renal insufficiency, regardless of albuminuria? Glucagon-like peptide-1 receptor agonists as a weapon against obesity?]
Angelo Avogaro, Alberto Corsini, Gianfranco Sinagra, et al.
Giornale Italiano Di Cardiologia (2006)
|
November 24, 2020
[Grey zones on diabetes in cardiovascular disease. Expert opinion]
Roberto Trevisan, Aurelia Grosu, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 24, 2015
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes
Gian Paolo Fadini, Benedetta Maria Bonora, Roberta Cappellari, et al.
Journal of Diabetes Science and Technology
|
October 16, 2012
Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center
Yoeri M Luijf, Angelo Avogaro, Carsten Benesch, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 8, 2005
Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit
Jeffrey M Lubow, Ivan G Piñón, Angelo Avogaro, et al.
Diabetes Care
|
February 10, 2007
Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location
Angelo Avogaro, Carlo Giorda, Marina Maggini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 27, 2010
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study
Riccardo C Bonadonna, Tim Heise, Christophe Arbet-Engels, et al.
Diabetes
|
April 30, 2020
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes
Serena Tedesco, Stefano Ciciliot, Lisa Menegazzo, et al.
Obesity (Silver Spring, Md.)
|
January 29, 2008
A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome
Lucia Gottardo, Salvatore De Cosmo, Yuan-Yuan Zhang, et al.
Diabetes Care
|
November 1, 2012
Diabetes impairs stem cell and proangiogenic cell mobilization in humans
Gian Paolo Fadini, Mattia Albiero, Saula Vigili de Kreutzenberg, et al.
Page
of 43
Search research articles
Search
Showing results (281-290 of 426) with videos related to
Sort By:
Page
of 43
Giornale Italiano Di Cardiologia (2006)
|
April 27, 2023
[Uncertainties in cardiovascular risk factors: sodium-glucose cotransporter 2 inhibitors for all diabetic patients with high cardiovascular risk and in all patients with renal insufficiency, regardless of albuminuria? Glucagon-like peptide-1 receptor agonists as a weapon against obesity?]
Angelo Avogaro, Alberto Corsini, Gianfranco Sinagra, et al.
Giornale Italiano Di Cardiologia (2006)
|
November 24, 2020
[Grey zones on diabetes in cardiovascular disease. Expert opinion]
Roberto Trevisan, Aurelia Grosu, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 24, 2015
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes
Gian Paolo Fadini, Benedetta Maria Bonora, Roberta Cappellari, et al.
Journal of Diabetes Science and Technology
|
October 16, 2012
Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center
Yoeri M Luijf, Angelo Avogaro, Carsten Benesch, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
September 8, 2005
Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit
Jeffrey M Lubow, Ivan G Piñón, Angelo Avogaro, et al.
Diabetes Care
|
February 10, 2007
Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location
Angelo Avogaro, Carlo Giorda, Marina Maggini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 27, 2010
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study
Riccardo C Bonadonna, Tim Heise, Christophe Arbet-Engels, et al.
Diabetes
|
April 30, 2020
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes
Serena Tedesco, Stefano Ciciliot, Lisa Menegazzo, et al.
Obesity (Silver Spring, Md.)
|
January 29, 2008
A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome
Lucia Gottardo, Salvatore De Cosmo, Yuan-Yuan Zhang, et al.
Diabetes Care
|
November 1, 2012
Diabetes impairs stem cell and proangiogenic cell mobilization in humans
Gian Paolo Fadini, Mattia Albiero, Saula Vigili de Kreutzenberg, et al.
Page
of 43